SCHEMBL28975285

SCHEMBL28975285

CCCC[Sn](CCCC)(CCCC)c1csc(OC(N)=O)n1

nearest known ligand 0.31

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
PLA2G4A P47712 1/20 0.31
CA12 O43570 1/20 0.30
CA1 P00915 1/20 0.30
CA2 P00918 1/20 0.30
CA9 Q16790 1/20 0.30
MEN1 O00255 1/20 0.30
NPC1 O15118 1/20 0.30
ALDH1A1 P00352 1/20 0.30
MAPT P10636 1/20 0.30
RAB9A P51151 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL303620 0.79
SCHEMBL1797891 0.77
SCHEMBL25372626 0.74 MAPK10 (0.31)
SCHEMBL28708344 0.73
SCHEMBL153957 0.72 ATP4A (0.35) PLA2G4ANPC1ALDH1A1MAPTRAB9A
SCHEMBL16783459 0.71 CYP1A2 (0.41) MEN1NPC1MAPTRAB9AKMT2A
SCHEMBL5638768 0.71
SCHEMBL18641392 0.70 KMT2A (0.42) MEN1NPC1MAPTRAB9AKMT2A
SCHEMBL1436781 0.70
SCHEMBL28975284 0.70 KAT2B (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110950860-B Fused tricyclic compound and application thereof in medicines 广东东阳光药业有限公司 2023-03-31 CN disclosed
CN-110950860-A Fused tricyclic compound and application thereof in medicines 广东东阳光药业有限公司 2020-04-03 CN disclosed